Get the Stockscreener App
0.68
1.45%
0.0097
After Hours:
.67
-0.01
-1.47%
Bone Biologics Corp stock is traded at $0.68, with a volume of 30,123.
It is up +1.45% in the last 24 hours and down -18.31% over the past month.
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
See More
Previous Close:
$0.6703
Open:
$0.6963
24h Volume:
30,123
Relative Volume:
0.21
Market Cap:
$2.29M
Revenue:
-
Net Income/Loss:
$-4.14M
P/E Ratio:
-0.0938
EPS:
-7.2511
Net Cash Flow:
$-4.79M
1W Performance:
-1.06%
1M Performance:
-18.31%
6M Performance:
-62.43%
1Y Performance:
-61.58%
1-Day Range:
$0.6603
$0.6963
1-Week Range:
$0.6603
$0.78
52-Week Range:
$0.64
$4.25
Bone Biologics Corp Stock (BBLG) Company Profile
Name
Bone Biologics Corp
Sector
Industry
Phone
(781) 552-4452
Address
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
0.68 | 2.29M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Bone Biologics Corp Stock (BBLG) Latest News
Orthobiologics Market Set to Witness Significant Growth - openPR.com
When (BBLGW) Moves Investors should Listen - news.stocktradersdaily.com
BBLG stock touches 52-week low at $0.7 amid market challenges - Investing.com Canada
BBLG stock touches 52-week low at $0.7 amid market challenges By Investing.com - Investing.com South Africa
Bone Biologics (OTC:BBLG) Trading 1.9% Higher – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Bone Biologics sets date for 2025 annual meeting - Investing.com
Top Trend In Orthobiologics Devices And Equipment Market 2025: Biodegradable Implants Transforming Orthobio... - WhaTech
Orthobiologics Market Future Business Opportunities - openPR.com
Theradaptive Welcomes Jeffrey W. Dunn to its Board of Directors - The Malaysian Reserve
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Update - Defense World
Bone Biologics (OTC:BBLG) Trading 1.2% Higher – Here’s Why - Defense World
MTF Biologics Collaborates with Kolosis BIO to Boost DBX Brand - World Business Outlook
MTF Biologics Expands Partnership with Kolosis BIO to Strengthen DBX Brand - StreetInsider.com
TETROUS®, INC. SUCCESSFULLY CLOSES FINANCING ROUND, SECURING ADDITIONAL CAPITAL FOR FUTURE GROWTH - PR Newswire
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Down 15.9% in February - Defense World
BBLG stock touches 52-week low at $0.8 amid market challenges - Investing.com
Orthobiologics Market Generated Opportunities, Future Scope - openPR
BBLG: Funding Looks Good as Trials Continue - Research Tree
Bone Biologics Corp SEC 10-K Report - TradingView
Orthobiologics Market : Comprehensive Overview, Trends, and Future Outlook 2025-2035 - PharmiWeb.com
Key Bone Void Fillers Market Trend 2025-2034: Advancements In Bone Healing Through Carbohydrate Polymer Tec... - WhaTech
Bone Biologics (BBLG) Expected to Release Quarterly Earnings on Wednesday - Defense World
Biodexa Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:BDRX - Benzinga
Bone Biologics (NASDAQ:BBLG) Stock Quotes, Forecast and News Summary - Benzinga
Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus.com
Trevi Therapeutics Inc (TRVI) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
OMI’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
CNQ’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
Edison International (EIX) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
BBLG’s Stock Journey: What Investors Need to Know About Bone Biologics Corp’s Performance - The InvestChronicle
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Up 9.8% in January - Defense World
(BBLGW) Technical Pivots with Risk Controls - Stock Traders Daily
Spine Biologics Market Research to 2030: Expansion Fueled - GlobeNewswire
Bone Biologics (OTC:BBLG) Trading Down 6.9% – Here’s Why - Defense World
The Bone Growth Products Market to Hit Revenue of $1.35 Billion by 2029, Mergers & Acquisition Trends Set to Drive Market ExpansionArizton - Industry Today
(BBLGW) Trading Report - Stock Traders Daily
An innovative advance in bone grafting: initial clinical results using a novel integrative bone graft in spinal fusion - Frontiers
Bone Biologics (OTC:BBLG) Trading Up 13% – Should You Buy? - Defense World
(BBLGW) Trading Advice - Stock Traders Daily
What Analysts Think About Bone Biologics Corp (NASDAQ: BBLG)’s Potential Raise - Stocks Register
Head to Head Contrast: Bone Biologics (NASDAQ:BBLG) vs. Establishment Labs (NASDAQ:ESTA) - Defense World
Orthobiologics Devices And Equipment Market Size, Growth, Trends And Forecast To 2033 - openPR
Orthobiologics Market Overall Study Report 2024-2031 | Zimmer - openPR
Bone Biologics updates ATM offering agreement terms By Investing.com - Investing.com Australia
Bone Biologics updates ATM offering agreement terms - Investing.com
Bone Biologics Corp Stock (BBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.01%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):